HOTLINE TOPIC |
|
N.A. Mukhin, MD., PhD., Prof; G.P. Arutyunov MD., PhD., Prof; V.V. Fomin MD., PhD. (Moscow)
Albuminuria as a marker of kidney injury and cardiovascular risk
|
|
А.V. Smirnov, MD., PhD., Prof; I.G. Kayukov, MD., PhD., Prof; V.A. Dobronravov, MD., PhD., Prof; A.G. Kucher MD., PhD. (Saint-Petersburg)
Acute kidney injury – a new definition in nephrology
|
11-15 |
STATE-OF-ART |
|
Yu. M. Zakharov (Chelyabinsk)
Citoprotective effects of erythropoietin.
|
16-21 |
G.E. Gendlin, MD., PhD., Prof; V.Yu. Shilo, MD.; N.A. Tomilina, MD., PhD., Prof; G.I Storogakov, MD., PhD., Prof; S.V. Borisovskaya, MD.; O.A. Ettinger, MD; S.V. Badaeva, MD.; O.A. Gavryushina, MD., PhD.
Left ventricular myocardial hypertrophy and its prognostic role at chronic kidney disease
|
22-28 |
G.P. Arutyunov MD., PhD., Prof; L.G. Oganezova, MD (Moscow)
Hyperfiltration in clinical practise
|
29-40 |
CLASSICS IN NEPHROLOGY |
|
|
41-43 |
PERSPECTIVE IN NEPHROLOGY |
|
I.E. Chazova, MD., PhD., Prof; V.V. Fomin, MD., PhD.; E.M. Paltseva MD., PhD.
Direct renin inhibitor aliskiren – new opportunities of kidney protection at hypertensive patients
|
44-49 |
ORIGINAL PAPERS |
|
Li O.A., I.N. Bobkova, MD, PhD, L.V. Kozlovskaya, MD, PhD, Prof
Urine levels of matrix metalloproteinases and their inhibitors as the marker of activity of chronic glomerulonephritis
|
50-54 |
N.Yu. Borovkova, MD, N.N. Borovkov, MD, PhD, Prof, B.N. Sidnev, MD, E.O. Obuhova MD
Heart rate variability, plasma renin activity and aldosterone level in chronic glomerulonephritis with arterial hypertension and normal renal function
|
55-58 |
M.M. Batiushin MD, PhD, Prof, E.S. Postnikova, MD, V.P. Terentiev MD, PhD, Prof, I.V. Dereviankina, MD
Correction of cerebro-renal syndrome in arterial hypertension with ischemic stroke: efficacy of eprosartan and hydrochlorothiazide
|
59-61 |
Yu.S. Milovanov, MD, PhD; L.V. Lysenko, MD, PhD, Prof; L.Yu. Milovanova, MD, I.A. Dobrosmislov, MD
Influence of low protein diet with balanced content of essential amino- and ketoacids and high-energetic nutrition mix, on renal failure progression of pre-dialysis chronic kidney disease caused by systemic diseases
|
62-66 |
NEPHROLOGICAL FORUM |
|
N.A. Mukhin, MD, PhD., Prof; E.M Shilov, MD, PhD, Prof; V.V. Fomin, MD, PhD; S.V. Moiseev, MD, PhD, Prof; M.Yu. Shvetsov, MD; L.Yu. Yurkevich
Atherosclerotic stenosis of the sole functioning kidney artery in patient with diabetes mellitus type 2 as a variant of kidney multimorbidity inelderly
|
68-71 |
DISCUSSION |
|
Mukhin N.A., MD, PhD, Prof; Martynov A.I., MD, PhD, Prof; Gyliarevsky S.R., MD, PhD, Prof; Fomin VV, MD, PhD.
Controversies in ACE inhibitors use
|
72-76 |
EVERYDAY CLINICAL PRACTICE NOTES |
|
M.V. Lebedeva, MD, PhD
Allopurinol: indications and tactics of prescription
|
77-79 |